希少疾患:医薬品メーカーと支払者の橋渡し
High prices for drugs for rare diseases have introduced uncertainties from payers around whether a medication’s value justifies its price.
High prices for drugs for rare diseases have introduced uncertainties from payers around whether a medication’s value justifies its price.